ARCHIVES

FDA Grants Priority Review To Two Drugs in NSCLC

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

NCCN’s First Physician CEO: Robert Carlson Pledges Broader Research and Policy Agenda

October 5, 2012

NCI Names 15 to Director’s Consumer Liaison Group.

January 14, 2005

NCI Study Finds No Greater Cancer Risk Near Nuclear Plants

September 28, 1990

Bypass Budget for FY 1989 to Ask $2 Billion For NCI, With Projection To $3 Billion by 1993

May 29, 1987

Federal Standards Improve Mammogram Quality, GAO Finds

November 17, 1995

New Design For NCI’s CancerNet Wins Prestigious Web Site Design Awards.

November 17, 2000